@article{be2d7e9d937747ee8d6c66d8fd7b38f4,
title = "Reply to Fern{\'a}ndez and Vazquez",
author = "Fang, {Ferric C.} and Robin Patel",
note = "Funding Information: grants from CD Diagnostics, BioFire, Curetis, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan, and The Medicines Company. R. P. is a consultant to Curetis; monies are paid to Mayo Clinic. In addition, R. P. has a patent on Bordetella pertussis/para-pertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued. R. P. receives travel reimbursement from Roche, the American Society for Microbiology (ASM), and the Infectious Diseases Society of America (IDSA); an editor{\textquoteright}s stipend from the ASM and the IDSA; and honoraria from the National Board of Medical Examiners, Up-to-Date, and the Infectious Diseases Board Review Course, outside the submitted work. F. C.",
year = "2019",
month = aug,
day = "30",
doi = "10.1093/cid/ciz083",
language = "English (US)",
volume = "69",
pages = "1087--1088",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "6",
}